Regulation of Blood and Blood products in India, USA and EU
Blood and blood products are precious commodity which gives life to another person. Though we have immense discoveries and invention in science and technology, yet we cannot make blood hence, human blood has no substitute. The availability of safe blood and blood products is essential for diverse modern healthcare services including some surgeries, treatments for cancer, chronic medical conditions, trauma care, organ transplantation, and childbirths that ultimately improve life for millions of patients who are need of transfusion annually. We do not have yet well-defined and stringent regulatory framework for blood products regulation. Frailty may arise from the inability of governments to enforce laws, regulations, and policies and personnel who may not aware or cannot follow quality assurance and/ or good manufacturing practices. While the health sector in developed nation has made outstanding accomplishments in the past few decades. The study sheds on the overview of blood transfusion system in India and other developed nations. There were a mix of methodologies, including literature review (government documents), interviews with key officials in Indian Red Cross Society and analysis of data was used. Results of analysis showed that there are several areas that need to be addressed as it potentially affect the timely availability of safe blood products, which calls for strengthening the planning and monitoring of blood transfusion services.
2. Component utilization [Internet]. TNMGRMU Repository; 2016 [cited 2017 Dec 13]. Available from:
3. Global Blood Safety and Availability – Key Facts and Figures 2016 [Internet]. World Health Organization; 2016 [cited 2018 Feb 23]. Available from:
4. Perez P, Salmi LR, Follea G, Schmit JL, et al, and the French Haemovigilance Network. Determinants of transfusion-associated bacterial contamination: results of the French BACTHEM Case-Control Study [Internet]. Pubmed; 2001 Jul [cited 2018 Feb 24]. 41(7):862-72. Available from Medline:
5. History of blood transfusion. Background of transfusion [Internet]. News Medical Lifesciences; 2017 [cited 2018 Mar 2]. Available from:
6. Highlights of Transfusion Medicine History [Internet]. AABB; 2018 [cited 2018 Mar 2] Available from:
7. American Society of Hematology. Blood Basics [Internet]. Washington: 2018 [cited on 12 December 2017] Available from:
8. Universal access to safe blood transfusion [Internet]. WHO; 2009 [cited 2018 Feb 17]. Available from:
9. Towards 100% Voluntary Blood Donation [Internet]. WHO global framework for action; 2010 [cited 2018 Mar 4] Available from:
10. U.S. Food and Drug Administration. Navigate the Vaccines, Blood & Biologics Section [Internet]. FDA; 2018 [cited 2018 Mar 5]. Available from:
11. British Committee for Standards in Haematology Guidelines [Internet]. Haematology Guidelines; 2017 [cited 2018 Jan 26]. Available from:
12. Regulatory requirements of blood bank [Internet]. CDSCO; 2012 [cited 2018 Mar 8]. Available from:
http://www.cdsco.nic.in/writereaddata/Drugs and CosmeticAct.pdf.
13. For grant/renewal of blood bank license [Internet]. CDSCO, 2012. [Cited 2018 Mar 8] Available from:
14. Approval process of blood bank establishment [Internet]. State drug control administration; 2017 [cited 2018 Mar 10]. Available from:
15. Blood donor selection [Internet]. WHO; 2018 [cited 2018 Mar 11]. Available from:
16. Eligibility criteria [Internet]. American Red Cross Society; 2018 [cited 2018 Mar 15]. Available from:
17. Indian blood bank [Internet]. donor guidelines; 2018 [cited 2018 Mar 16)]. Available from:
18. Donor selection principle [Internet]. IPFA Workshop SPIER Stellenbosch; 2015[cited 2018 Mar 5]. Available from:
19. World Health Organisation: Recruiting, Educating and Retaining [Internet]. Safe Blood Donors Geneva, Switzerland: World Health Organization; 2010 [cited 2018 Mar 10]. Available from:
20. Donor eligibility [Internet]. AABB; 2018 [cited 2018 Mar 17]. Available from:
21. Donor inclusion and exclusion criteria [Internet]. NACO; 2017. [Cited 2018 Mar 18 ] Available from:
22. Blood- European Commission. Requirements for donation [Internet]. EMEA; 2018 [cited 2018 Mar 20] Available from:
23. Donor deferral guideline. WHO Safe Blood Safe Donor Selection [Internet]. WHO; 2009. [cited 2018 Mar 15]. Available from:
24. FDA regulation for donor screening devices. Testing protocol [Internet].FDA; 2018 [cited 2018 Mar 24]. Available from:
25. FDA. Requirements for Blood and Blood Components Intended for Transfusion or for Further Manufacturing Use [Internet]. Federal Register; Vol. 80, No. 99; 2015 May 22 [cited 2018 Mar 25]. Available from:
26. FDA- Reporting requirements [Internet]. MEDWATCH form; 2018 [cited 2018 Mar 25]. Available from:
27. FDA- Reporting requirements [Internet]. FDA; 2018. [cited 2018 Mar 25]. Available from:
28. National Guidelines for HIV testing [Internet]. National AIDS Control Organisation; 2015 [cited 2018 Mar 23]. Available from:
29. Quality Control of ABO and Rh blood grouping reagents [Internet]. Guidance Manual; 2012 [cited 2018 Mar 26]. Available from:
30. Classification of devices [Internet]. CDSCO new rule; 2018 [cited 2018 Mar 28]. Available from: http://www.cdsco.nic.in/writereaddata/Classification%20of%20Medical%20devices%20and%20_updated.pdf
31. EU Standards of quality of blood product [Internet]. Guidelines for blood establishment; 2006 [cited 2018 April 1]. Available from:
Directive 2001/83/EC: https://ec.europa.eu/health/sites/health/files/files/eudralex/vol1/dir_2002_ 98/dir_2002_98_enpdf
32. EU Technical requirements of blood. Technical requirements for blood and blood components [Internet]. EMEA; 2004 [cited 2018 April 12]. Available from:
33. European regulation of IVD [Internet]. Classification of IVD; 2012 [cited 2018 April 13]. Available from:
34. EU blood establishment inspection system [Internet]. Quality management; 2006 [Cited 2018 Apr 18]. Available from:
35. Standards for blood storage centres [Internet]. Ministry of Health and Family Welfare-NACO; 2009 [cited 2018 April 19]. Available from:
36. AABB Standards for storage and transport [Internet]. Blood Products by Temperature Group; 2016 [cited 2018 April 20]. Available from:
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM
Rights of Authors:
The International Journal of Drug Regulatory affairs. recognize the retention of the following:
- Patent and trademark rights and rights to any process or procedure described in the article.
- The right to photocopy or make single electronic copies of the article for their own personal use, including for their own classroom use, or for the personal use of colleagues, provided the copies are not offered for sale and are not distributed in a systematic way outside of their employing institution (e.g. via an e-mail list or public file server). Posting of an article on a secure network (not accessible to the public) within the author’s institution is permitted.
- The right, subsequent to publication, to use the article or any part thereof free of charge in a printed compilation of works of their own, such as collected writings or lecture notes.
Note: All copies, paper, electronic or other use, of the information must include an indication of the IJDRA copyright and a full citation of the journal source.
- If the article was prepared jointly with other author(s), the signing author has informed the co-author(s) of the terms of this copyright transfer and is signing on their behalf as their agent and represents that he or she is authorized to do so, then please confirm by checking the appropriate box following the signature line. The signing author shall bear the responsibility for designating the co-author(s) and must inform the IJDRA of any changes in authorship.
- If copyright is held by the employer, then the employer or an authorized representative of the employer must sign. If the author signs, it is understood that this is with the authorization of the employer and the employer’s acceptance of the terms of the transfer.
The author(s) warrant(s) that the article is the author’s original work and has not been published before. The author(s) warrant(s) that the article contains no libelous or other unlawful statements, and does not infringe on the rights of others. If excerpts from copyrighted works are included, the author(s) has (have) obtained or will obtain written permission from the copyright owners and will credit the source in the article.
Preprints: The author(s) must agree that if a prior version of this work (normally a preprint) has been posted to an electronic public server, they will not update and/or replace the prior version in order to make it identical in content to the final published version.